EndoVentions

San Rafael, United States Founded: 2019 • Age: 7 yrs
Develops innovative devices for treating kidney stones.
Annual revenue - Latest available
Total funding - Funding intelligence
Employees - Tracked headcount
Investors - Known backers
Products - Services tracked
Competitors 11 Brand Intelligence

About EndoVentions

EndoVentions is a company based in San Rafael (United States) founded in 2019 by Marc Levinson. It operates as a B2B. EndoVentions operates in a competitive market with competitors including Axonics, Laborie Medical, Amber Therapeutics, NeuSpera Medical and Atlantic Therapeutics, among others.

  • Headquarter San Rafael, United States
  • Founders Marc Levinson
  • Sectors
    Healthcare
  • Phone
    Locked
  • Website
    Locked
  • Social
    Locked
Operational Areas
Healthcare → Healthcare Products & Supplies Unlock Sub-Sector Unlock Segment
Key Metrics
  • Annual Revenue
    Not available
  • Net Profit
    Not available
  • EBITDA
    Not available
  • Latest Funding Round
    Not available
  • Investors
    Not available
  • Employee Count
    Not available
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Funding Insights of EndoVentions

Premium access

Detailed funding history for EndoVentions

Round names, dates, amounts, investors, and valuation history require an active premium plan.

  • Round names and dates
  • Funding amounts
  • Participating investors
  • Valuation history

Verified entity values are shown only after access is granted.

Investments & Acquisitions by EndoVentions

Investments
Premium access

Investment portfolio details for EndoVentions

Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.

  • Portfolio identities
  • Transaction dates
  • Round details
  • Investment values

Verified entity values are shown only after access is granted.

Financial Statements - EndoVentions

Premium access

Detailed financials for EndoVentions

Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.

  • Historical revenue
  • Profit trends
  • Statement rows
  • Financial ratios

Verified entity values are shown only after access is granted.

Endoventions Comparisons

EndoVentions Primary company
Description
Develops innovative devices for treating kidney stones.
Location
San Rafael, United States
Founded Year
2019
Annual Revenue
Not available
Net Profit
Not available
EBITDA
Not available
Employees
Not available
Premium access

Peer comparison for EndoVentions

Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.

  • Named peers
  • Headcount comparison
  • Funding comparison
  • Operating benchmarks

Verified entity values are shown only after access is granted.

+
Add Comparison
Available on Premium

Competitors of EndoVentions

EndoVentions operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Axonics, Laborie Medical, Amber Therapeutics, NeuSpera Medical and Atlantic Therapeutics, among others.

Company Name Domain Founded year HQ Location Description
Locked Locked Locked
Sacral neuromodulation devices are developed for urinary and bowel control.
Locked Locked Locked
Medical products for female lower urinary tract dysfunctions are provided.
Locked Locked Locked
Bioelectrical therapies for peripheral nervous system disorders are developed.
Locked Locked Locked
Miniaturized injectable neuromodulation devices are developed for chronic diseases.
Locked Locked Locked
Non-invasive wearable devices for pelvic floor strengthening are developed.
Locked Locked Locked
Developer of active implantable devices for urological incontinence
Premium access

Detailed competitors of EndoVentions

Competitor domains, locations, full profiles, and operating metrics require an active premium plan.

  • Domains and locations
  • Full company profiles
  • Operating metrics
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on Endoventions

Premium access

Complete news archive for EndoVentions

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about EndoVentions

EndoVentions was founded in 2019.

EndoVentions is headquartered in San Rafael, United States. It is registered at San Rafael, California, United States.

Marc Levinson is the current CEO of EndoVentions. They have also founded this company.

EndoVentions develops innovative devices for treating kidney stones through providing healthcare solutions, developing medical devices, urology, and kidney stone treatment. Prioritizing client-centric approaches, it ensures high-quality outcomes, innovation, and sustainable practices in its field. It continues to evolve, meeting industry challenges with strategic approaches.

EndoVentions's top competitors include Axonics, NeuSpera Medical and Laborie Medical.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available